01:15 28-11-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Japan ready to offer flu drug for Ebola treatment

Bishkek (AKIpress) - ebola in Africa Japanese officials are ready to provide an anti-flu drug as a potential treatment to fight the rapidly-expanding Ebola outbreak, the Associated Press reports.

Chief Cabinet Secretary Yoshihide Suga said that Japan can offer the favipiravir tablet, developed by a subsidiary of Fujifilm Holdings, any time at the request of the World Health Organisation.

The drug, developed by Fujifilm subsidiary Toyama Chemical to treat novel and re-emerging influenza viruses, was approved by the Japanese health ministry in March.

Fujifilm spokesman Takao Aoki said ebola and influenza viruses are the same type and theoretically similar effects can be expected on Ebola.

He said the drug has also proved effective in lab experiments on mice.

Fujifilm said it has favipiravir stock for more than 20,000 patients.

The company is also in talks with the US Food and Drug Administration on clinical testing of the drug in treating Ebola.

Favipiravir is one of only a few drugs that may work on Ebola.

Recently, two Americans have been treated with another experimental drug called ZMapp, developed by San Diego Mapp Biopharmaceutical.

Ebola has killed more than 1,400 people in west Africa in the latest outbreak.


Twitterfacebookprint
16:22 25.08.2014
LATEST NEWS
17:49 Switzerland represents Latvia in visa matters in Kyrgyzstan17:43 UNHCR, State Registration Service update action plan on prevention and reduction of statelessness17:39 Kyrgyzstan presents online performances of manaschy, Kyrgyz folk music to Czech Republic and Malaysia17:31 Kyrgyzstan needs to attract $7 billion of investments annually – Economy Minister17:22 Kyrgyzstan lacks accurate data on total number of cattle – MP17:14 Health Ministry working to prevent introduction, spread of Ebola virus in Kyrgyzstan – Government17:02 Polish entrepreneurs reportedly set to build car factory in Kochkor district17:00 Oil price at four-year low as Opec meets16:56 Uzbekistan proposes Russia to export vegetables directly without Kazakhstan's intervention – Deputy PM16:55 U.S. Ambassador to hold public lecture on cooperation with OSCE on Central Asia's security issues16:49 Bishkek City Council approves allotment of 3 mln som for development of hostel for persons of no fixed abode16:40 Czech President completes his official visit to Tajikistan16:39 Vice PM of Kyrgyzstan, Federal Government Commissioner of Germany discuss cultural and humanitarian cooperation16:29 Kazakh delegation participates in General Assembly of International Exhibitions Bureau16:13 3,405 documents for permanent residence processed in January-September 201416:02 National Institute for Strategic Studies, Institute of Central Asia Studies at Shaanxi Normal University sign memo of cooperation15:50 Ombudsman: 60% of appeals, complaints fall at law enforcement, judicial agencies15:44 $13 million tax debt of Tajikistani railway company written off - decree15:40 Education Ministry introduces AVN system to improve efficiency of public services in education sector15:23 Tajikistan blocks drug supply chain from Afghanistan to CIS countries
Astana
-19° C
Ashgabat
+6° C
Bishkek
-6° C
Dushanbe
+9° C
Tashkent
+1° C
exchange rates
 
71.82
57.58
9.40
1.24
225.49
180.87
29.47
3.88
6.34
5.09
0.83
0.11
3042.15
2388.25
390.42
56.91
3.55
2.85
0.46
0.06

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75